Picture of Tourmaline Bio logo

TRML — Tourmaline Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Talaris Therapeutics Announces Q3 Financial Results

Nov 10 (Reuters) - Talaris Therapeutics Inc  TALS.O :
    * TALARIS THERAPEUTICS ANNOUNCES THIRD QUARTER FINANCIAL
RESULTS
AND CORPORATE UPDATE
    * TALARIS THERAPEUTICS INC Q3 LOSS PER SHARE $0.46
    * TALARIS THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.46

Source text for Eikon:  ID:nGNX3FppCX 
Further company coverage:  TALS.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Tourmaline Bio

See all news